Aguilar Richard's Form 4 filing
Cano Health, Inc. (CANO) · filed Jun 13, 2023
- Accession no.
- 0001209191-23-036903
- Filed
- Jun 13, 2023
- Trade date
- May 25-Jun 12, 2023
- Filing delay
- 19 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.73M. It was filed 19 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aguilar RichardCIK 0001865481 | Officer (Chief Clinical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 25, 2023 | Class A Common Stock | CConversionAcquired | +675,940 | $0.00F1 | $0 | 1,889,924 | Direct | |
| May 25, 2023 | Class A Common Stock | CConversionAcquired | +600,000 | $0.00F1 | $0 | 600,000 | Indirect | |
| Jun 7, 2023 | Class A Common Stock | SSaleDisposed | −400,000 | $1.32F3 | −$528,000 | 1,489,924 | Direct | |
| Jun 8, 2023 | Class A Common Stock | GGiftDisposed | −600,000 | $0.00 | $0 | 0 | Indirect | |
| Jun 8, 2023 | Class A Common Stock | GGiftAcquired | +600,000 | $0.00 | $0 | 2,089,924 | Direct | |
| Jun 8, 2023 | Class A Common Stock | SSaleDisposed | −275,940 | $1.29F4 | −$355,962.6 | 1,813,984 | Direct | |
| Jun 9, 2023 | Class A Common Stock | SSaleDisposed | −100,000 | $1.38F5 | −$138,000 | 1,713,984 | Direct | |
| Jun 12, 2023 | Class A Common Stock | SSaleDisposed | −500,000 | $1.42F6 | −$710,000 | 1,213,984 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 25, 2023 | Class A Common Stock | CConversionDisposed | −675,940 | $0.00 | $0 | 0 | Direct | |
| May 25, 2023 | Class A Common Stock | CConversionDisposed | −675,940 | $0.00 | $0 | 0 | Direct | |
| May 25, 2023 | Class A Common Stock | CConversionDisposed | −600,000 | $0.00 | $0 | 5,292,276 | Indirect | |
| May 25, 2023 | Class A Common Stock | CConversionDisposed | −600,000 | $0.00 | $0 | 5,292,276 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects an exchange of Primary Care (ITC) Intermediate Holdings, LLC ("PCIH Common Units"), together with the surrender and cancellation of the same number of shares of the Issuer's Class B Common Stock, par value $0.0001 per share ("Class B Common Stock"), for an equal number of shares of the Issuer's Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), pursuant to the Second Amended And Restated Limited Liability Company Agreement of Primary Care (ITC) Intermediate Holdings, LLC (the "LLC Agreement"). Transactions are exempt from Section 16(b) in reliance on Rule 16b-6(b).
Referenced by the price of 2 transactions in Table I.
- F3
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.30 to $1.35. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.26 to $1.33. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.365 to $1.39. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.